Gastric Cancer
Reports from Kyoto University, Medical Department highlight recent research in gastric cancer
Published in Drug Week, January 15th, 2010
"In 41 patients diagnosed with either macro- or microscopic peritoneal dissemination by staging laparoscopy, and receiving induction chemotherapy with S-1 plus cisplatin between August 2002 and February 2008, response of peritoneal lesions to the induction chemotherapy and the outcome of the following surgery were retrospectively evaluated. Of 41 patients identified, 38 patients (93%) completed two cycles. Among grade 3 or 4 adverse effects,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-01-15)
More Articles from Drug Week
- American Academy of Neurology
Guideline: Widely used device for pain therapy not recommended for chronic low back pain - American Associates, Ben-Gurion University of the Negev
Anti-inflammatory drugs coxibs interfere with aspirin's clotting ability -- Ben-Gurion U. - Institute for Research in Biomedicine IRB Barcelona
Researchers design a tool to induce controlled suicide in human cells - JAMA and Archives Journals
Findings suggest cardiovascular devices often approved by FDA without high-quality studies - Journal of the National Cancer Institute
Assessing lead time of selected ovarian cancer biomarkers - Journal of the National Cancer Institute
News brief: Knockdown of E2F1 reduces invasive potential of melanoma cells - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
